Bayer Cropscience India Limited · NSE:BAYERCROP

Bayer Cropscience India — Bayer CropScience — Investor Presentation (September 2013)

15 slides from Bayer Cropscience India's investor presentation, Sep 5, 2013

  1. Slide 1: Investor Presentation Bayer CropScience Ltd., India

    Investor Presentation Bayer CropScience Ltd., India September 5, 2013

  2. Slide 2: Content

    Content Market and BCSL Business BCSL Financials Business Outlook and Strategy Slide 2 • Bayer CropScience Ltd. • Investor Presentation 09/05/2013

  3. Slide 3: Early monsoon and excessive rainfall lead to an ahead of schedule planting season

    Early monsoon and excessive rainfall lead to an ahead of schedule planting season +11% monsoon rainfall till now Reservoir level status  Reservoir levels +45% over last year  39% above last 10 years average  Filling up of water reservoirs is a positive indication for the Rabi season Slide 3 • Bay

  4. Slide 4: Favorable market environment supports increase in revenue in first Quarter 2013/14

    Favorable market environment supports increase in revenue in first Quarter 2013/14 Agricultural Market BCSL  Early onset of monsoon and early sowing  Active product placement for Kharif crops  Season expected to peak early  Market consumption increased significantly  Government has announced in

  5. Slide 5: Content

    Content Market and BCSL Business BCSL Financials Business Outlook and Strategy Slide 5 • Bayer CropScience Ltd. • Investor Presentation 09/05/2013

  6. Slide 6: Double digit growth in Indian market

    Double digit growth in Indian market April to June 2013 BCSL Sales Other Operating Other (INR Mio) Domestic Export Revenue Income (Change over Previous year) 10% 9% 2% 5% 7% 776 107 5 11 10,108 9,433 Net Sales 669 +7% 2012-13 2013-14 As % to Total 2013/14 86 10 2 2 Revenue 2012/13 83 13 2 2 Slide 6

  7. Slide 7: First quarter's profitability loaded with investment in advertising and personnel

    First quarter’s profitability loaded with investment in advertising and personnel April to June 2013 BCSL Profitability* (INR Mio) Gross Other Operating Employees Other Depreciation & Profit & Other Income Expenses Expenses Finance Cost (Change over Previous Year) 1% 1% 15% 16% 2% 13% 36 6 74 173 1,

  8. Slide 8: Major changes in Balance Sheet due to consolidation measures

    Major changes in Balance Sheet due to consolidation measures (INR Mio, Figures in chart %) Balance as on June 30, 2013 June 30, 2012 Fixed Assets 3,739, 51% Fixed Assets 2,479 Shareholders Shareholders Cash & Bank Funds 20,189 Cash & Bank Balance Funds 8,814 Balance 4,110 +++% 7 9,025, +++% 5 19 9 1

  9. Slide 9: BCSL with a strong stock performance in the last year

    BCSL with a strong stock performance in the last year BCSL +51.4% Sensex +6.8% Peer Index +7.6% indexed; 100 = closing price on August 31, 2012 (source: BSEIndia.com) Bayer BSE Peer Index 100 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug- 13 Notes: Period: A

  10. Slide 10: Content

    Content Market and BCSL Business BCSL Financials Business Outlook and Strategy Slide 10 • Bayer CropScience Ltd. • Investor Presentation 09/05/2013

  11. Slide 11: BCSL optimized its infrastructure and balanced the utilization of funds

    BCSL optimized its infrastructure and balanced the utilization of funds Thane Powai Head Office The sale of the Thane campus where The former Bayer Head Office -“Bayer BCSL is hosting ca. 800 Bayer House”- in Powai was sold to employees was finalized end of 2012 Hiranandani Group in March 2013 Infra

  12. Slide 12: The business outlook is promising and BCSL is following an ambitious growth strategy

    The business outlook is promising and BCSL is following an ambitious growth strategy Business Outlook & Strategy India is a core country for global Bayer CropScience business BCSL strengthen the number one leadership position with its combined Crop Protection and Seeds portfolio New integrated crop

  13. Slide 13: Summary

    Summary  Favorable early monsoon and good rainfalls  Strong growth in domestic revenues  BCSL share price outperformed the market  Strategic infrastructure consolidation  Positive business outlook  BCSLs strategy shows high commitment in Indian market Page 13 • Bayer CropScience Ltd. • Investo

  14. Slide 14: Disclaimer

    Disclaimer Forward-Looking Statements This presentation contains forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual as

  15. Slide 15: Thank You

    Thank You BAYER E R Science For A Better Life

Bayer CropScience — Investor Presentation (September 2013) on 6ix